Key messages by Fabrice Andre at ESMOBreast24 session on ctDNA for clinical decision making 

Elisa Agostinetto, Medical Oncologist and Research Physician at Jules Bordet, shared on X: .

“At ESMOBreast24 session on ctDNA for clinical decision making. Two key messages by Fabrice Andre:

• The more the disease advances, the more the genomic profile is complex (and harder to treat!) 
• The more the disease is advanced, the rise of resistance clones”

Source: Elisa Agostinetto/X